Hematology Oncology Physician jobs in Phoenix Arizona

Hematology - Oncology Physician Job Description & Requirements Hematology - Oncology Physician StartDate: ASAP Available Shifts: 24;On Call Pay Rate: $3637.50 - $3937.50 This facility is seeking a Hematology - Oncology Physician for locum tenens support as they look to fill a current need. Details & requirements for this opportunity: Monday through Sunday, 24 hour call shifts Inpatient Service Standard Hematology - Oncology Cases 12-15 consults on average per week Credentialing Timeframe: 30 to 60 days Facility Location With its endless sunshine, spectacular desert landscape and eclectic mix of museums, culture, sport and outdoor adventures, Phoenix is a popular destination any time of the year. Whether shopping, dining, horseback riding or lounging at the pool, this thriving oasis offers an excellent quality of living and career-boosting assignments at its most prestigious facilities. Job Benefits AMN Healthcare typically arranges medical or dental malpractice insurance for the contractor providers we match to client opportunities. In addition, our locum tenens can receive highly competitive pay and a dedicated team that handles all travel, lodging, rentals and transportation needs. About the Company At AMN Healthcare, we strive to be recognized as the most trusted, innovative, and influential force in helping healthcare organizations provide quality patient care that continually evolves to make healthcare more human, more effective, and more achievable. Internal Medicine, Hematologist Oncologist, Ho, Hematology Oncologist, Oncology, Oncologist, Blood, Blood Illness, Blood Cells, Physician, Md

Faculty Position: Early Cancer Detection and Interception Physician and Scientist Investigators Up to two positions may be filled, with appointments based at either Mayo Clinic Arizona or Mayo Clinic Rochester. Position Description The Mayo Clinic and Mayo Clinic Comprehensive Cancer Center (MCCCC) in Phoenix and Scottsdale, Arizona, and in Rochester, Minnesota, invite applications for open-rank faculty positions in Early Cancer Detection and Interception with strong leadership potential and a commitment to advancing cancer research into clinical impact. Mayo Clinic and MCCCC have built a world-class research hub to transform cancer patient care through actionable target discovery and next-generation discovery and therapeutic platforms. These foundational platforms include Mayo Clinic Platform which holds the fully digitized longitudinal patient records from 15M Mayo Clinic patients and 54M patients from across the nation and the globe with collaborating healthcare institutions, which facilitate research through development of longitudinal patient cohorts prior to and following disease diagnosis. Mayo Clinic has also developed very strong AI-driven discovery, translational, and clinical programs with exceptional "on premises" and cloud-based computational resources. These AI programs focus on multimodal virtual cell and organ predictive modeling, digital twins, and AI-based early cancer detection and interception, drug discovery, and guided intervention. MCCCC also created one of the nation's first National Cancer Institute (NCI)-Designated Cancer Center Research Programs focused on early cancer detection and interception: Cancer Risk Assessment, Early Detection, and Interception (REDI). These positions will focus on leading transformative spanning from discovery to translational to clinical science efforts in cancer early detection, prevention, and data-driven translational and clinical. This role will integrate discovery and translational science, clinical care, genomics, advanced analytics, and community engagement to redefine how cancer is detected early, monitored, and prevented. Particular focus will be in the field of cancer interception - delaying or preventing cancer development or progression of nascent disease-particularly in pre-cancer and high-risk populations. Strategic Role and Leadership Expectations The Early-Detection and Interception Physician and Scientist Investigators will: Design and lead prospective cohorts of healthy individuals and high-risk populations to study cancer initiation, progression, and interception. Develop strategies to identify individuals at risk (pre-cancer) and guide them to appropriate screening, prevention, and early intervention pathways. Integrate clinical, genomic, and longitudinal health data to monitor disease evolution and enable early therapeutic intervention and clinical trials. Partner with institutional programs (e.g., Mayo Clinic Platform, the Mayo Clinic AI Program, the Center for Individualized Medicine, the Department of Laboratory Medicine and Pathology, Clinical Genetics) to implement comprehensive, clinical-grade genomic sequencing initiatives or other AI-based multimodal predictive algorithms for early cancer detection and guiding interception in community-based screening and clinical settings. Expand cancer risk evaluation to include AI-driven, multi-parametric models incorporating multiple variables (eg. longitudinal clinical data, radiomics, digital pathology, genetics/genomics, exposome, epidemiology and behavioral data, etc.). Expand access to advanced genomic diagnostics across diverse care settings and utilized genomic insights to inform risk assessment, early detection, and personalized treatment strategies. Collaborate with discovery science investigators to develop, test and validate novel methods for early cancer detection and diagnosis. Lead and develop a translational science program focused on early detection, cancer interception (including immunoprevention). Utilize data warehouses unifying clinical, genomic, imaging, and outcomes data. Lead the development of data surveillance and visualization tools to monitor cancer trends across patient populations and communities. Partner with clinical and community organizations to build collaborative, community-based clinical trial networks, focused on prevention and early detection/screening trials. Expand access to innovative trials and precision medicine approaches in diverse and underserved populations. Extend institutional impact nationally and globally through scalable models of care and research. The successful candidates will build and lead large-scale, longitudinal patient cohorts; drive discovery science and/or develop clinical-grade genomic programs; and leverage integrated data platforms, artificial intelligence, and digital health tools to improve patient outcomes and expand access to cutting-edge care Research Environment Mayo Clinic offers a highly collaborative and integrated academic medical center environment with expanding strengths in cell therapy, cancer immunotherapy, regenerative medicine, and translational science. Faculty benefit from: Established CAR-T and immune cell therapy programs with active clinical translation State-of-the-art genome engineering and cell manufacturing infrastructure Access to institutional core facilities including genomics, single-cell sequencing, proteomics, bioinformatics, advanced imaging, computational resources and AI tools. Focused drive to launch first-in-human trails to bring new treatments to patients Dedicated institutional support for regulatory strategy, clinical trial development, and commercialization pathways Developing biotechnology corridor attracting partner companies for the accelerating translation of discoveries. Cross-campus enterprise collaboration opportunities with the three Mayo Clinic Destination Medical Center Sites (Rochester, Minnesota; Jacksonville, Florida; and Phoenix and Scottsdale, AZ). The selected candidates may house their programs on either the Mayo Clinic Arizona or Minnesota campuses but will work across the Mayo Clinic enterprise. They will help shape a coordinated, forward-looking therapy strategy that advances precision medicine for cancer risk determination and clinical translation of therapeutics directed at preventing cancer development or progression of nascent disease. Why Mayo Clinic Comprehensive Cancer Center (MCCCC)? With 440 members and >1500 aligned cancer physicians working in six Cancer Research Programs (Cancer Prevention, Survivorship & Control; Cancer Risk Assessment, Early Detection & Interception; Cancer Genomics, Signaling, & Metastasis; Cancer Immunology & Immunotherapeutics; Novel Therapeutics & Therapeutic Modalities; Advanced Clinical Trials and Translational Sciences) and 15 Disease Groups focused on clinical trials, MCCCC is a global leader and represents the pinnacle of cancer care, research and education and training. Every year, across its three enterprise sites (Rochester, Minnesota; Phoenix and Scottsdale, Arizona; and Jacksonville, Florida), MCCCC physicians provide expert cancer diagnosis and treatment to more than 150,000 unique patients from across the nation and the globe. The MCCCC Misson: To inspire hope and promote health and healing through integrated research, clinical practice, and education, centered around our primary value: the needs of the patient come first. The MCCCC Vision: To be a global cancer authority: transforming cancer research and practice to assure that our discoveries, knowledge, and expertise are accessible to all, within and beyond our walls, at anyplace and anytime. MCCCC Goals: To cure cancers through translation of innovative transdisciplinary science to new means of prevention, early detection, interception, intervention, and unparalleled care delivery. To transform cancer research and practice using category of one data platforms, digital technologies, artificial intelligence (AI), and intelligent automation, creating new models for community and patient engagement, and the conduct of research, clinical trials and patient-centered care delivery in clinical, home, and community settings. To use Mayo Clinic Platform to engage patients and communities in our catchment areas and across the nation and the world in cancer research and distributed and decentralized clinical trials. To educate, train, and mentor the next generation of cancer physicians, scientists, and leaders. Over the past year, MCCCC has continued to achieve exceptional performance metrics, with high levels of cancer research funding (reporting $61.2M in annual peer-reviewed funding ($41.1M from NCI) and $98.7M in industry and non-peer reviewed funding). The Center currently has over 80 multi-investigator programmatic grants including 6 NCI Specialized Programs of Research Emphasis (SPORES): Myeloma, Ovarian Cancer, Breast Cancer, Liver/Hepatobiliary Cancers, Prostate Cancer, and Sarcoma. In 2025, clinical trial accrual has remained robust, reporting the Center's highest accrual to therapeutic interventional trials: 2,624 (12% of newly registered cases), with 6,588 interventional accruals (30% of newly registered patients) and 10,367 non-interventional accruals. In 2025, MCCCC members published an exceptional number (1776) of peer-reviewed academic works, 24% of which were published in high impact journals. Why Choose Mayo Clinic? Mayo Clinic is a premier, integrated academic medical center consistently ranked among the top hospitals in the nation. All campuses are experiencing strategic growth in cancer immunotherapy, drug discovery & development, regenerative medicine, and translational discovery science. We offer: Competitive startup and sustained institutional support Investment in team science and program-building initiatives Access to a $1B+ annual research enterprise Infrastructure for IND-enabling studies and early-phase clinical trials Exceptional benefits, including retirement and pension programs A culture that values innovation, inclusion, and transdisciplinary collaborationTo apply for this position, please use the apply option on this page.

Breast Medical Oncologist The Division of Medical Oncology and Hematology seeks an early- to mid-career medical oncologist to join and help expand the Mayo Clinic Arizona Breast Cancer Program. The ideal candidate will have a strong clinical and academic focus in breast oncology, with a commitment to advancing patient care, clinical research, and innovation. This role includes participation in a multidisciplinary breast cancer clinic, development and leadership of investigator-initiated and cooperative group clinical trials, mentorship of trainees and junior faculty, and recruitment of future colleagues. The successful candidate will have the opportunity to build a nationally and internationally recognized academic practice while helping shape the future of breast cancer care across the continuum of disease. Cancer care at Mayo Clinic is delivered collaboratively across Arizona, Florida, and Minnesota, providing access to enterprise-wide resources that include more than 250 hematologists and oncologists, over 2,000 faculty members involved in cancer care, state-of-the-art CORE research facilities, world-class pathology services, and integrated clinical and translational data platforms. The Breast Cancer Program actively participates in the Alliance for Clinical Trials in Oncology, the NCI Experimental Therapeutics Clinical Trials Network (ETCTN), and numerous industry-sponsored and international collaborative studies. The program is further strengthened by participation in a Breast Cancer Specialized Program of Research Excellence (SPORE), creating unique opportunities for translational and clinical investigation. The Division also supports an ACGME-accredited Hematology/Oncology Fellowship and the highly ranked Mayo Clinic Alix School of Medicine in Arizona, providing abundant opportunities for education and mentorship. Mayo Clinic maintains a strategic alliance with Arizona State University (ASU), established in 2016 through the Mayo Clinic and ASU Alliance for Health Care. This collaboration spans biomedical research, digital health, workforce development, and medical technology innovation. The nearby ASU Health Futures Center and the rapidly growing Discovery Oasis biotechnology corridor, located adjacent to the Mayo Clinic campus, further enhance opportunities for scientific collaboration and innovation. Faculty may hold adjunct appointments at ASU and engage in collaborative research and educational activities with ASU faculty and trainees. Mayo Clinic continues to make substantial investments in the expansion of its Phoenix campus, including significant growth in clinical, research, and educational infrastructure. Located in Phoenix and Scottsdale, our Arizona campuses offer an exceptional professional environment and an outstanding quality of life in the Sonoran Desert. This is an exciting and pivotal time to join a rapidly growing Breast Cancer Program and contribute to the future of breast cancer care, research, and education at Mayo Clinic.

Hematologist - Lymphoma and Cell Therapies The Division of Hematology and Medical Oncology seeks a mid-career to senior hematologist specializing in lymphoma and cellular therapies to join and help expand the Mayo Clinic Arizona Cellular, Molecular and Bispecific (CMB) Therapies Program. Candidates should hold or be eligible for Associate Professor rank or higher and ideally have established peer-reviewed funding. This role includes participation in a multidisciplinary lymphoma clinic, development and leadership of clinical trials, mentorship of trainees and junior faculty, and recruitment of future colleagues. The successful candidate will build a nationally and internationally recognized academic practice while driving innovation across the spectrum of lymphoma care. Cancer care at Mayo Clinic is delivered collaboratively across Arizona, Florida, and Minnesota, providing access to enterprise-wide resources, including more than 250 hematologists and oncologists, over 2,000 faculty involved in cancer care, CORE research facilities, pathology, and integrated clinical data systems. The Lymphoma Cancer Program actively participates in the Alliance for Clinical Trials in Oncology, the NCI Experimental Therapeutics-Clinical Trials Network (ETCTN), and multiple industry-sponsored and international collaborative studies. Mayo Clinic maintains a strategic alliance with Arizona State University (ASU), formalized in 2016 through the Mayo Clinic and ASU Alliance for Health Care. This collaboration spans biomedical research, digital health, workforce development, and medical technology. The nearby ASU Health Futures Center and the developing Discovery Oasis biotechnology corridor-on 250 acres adjacent to Mayo Clinic-further strengthen research and innovation opportunities. Faculty may hold adjunct ASU appointments and collaborate with ASU trainees. Mayo Clinic is investing significantly in the expansion of its Phoenix campus, including clinical, research, and educational infrastructure. Located in Phoenix and Scottsdale, our Arizona campuses offer an exceptional professional and personal environment in the Sonoran Desert. This is a pivotal time to join our growing division and contribute to the future of lymphoma and cellular therapy care at Mayo Clinic.

Medical Oncologist - Melanoma and Cutaneous Malignancies The Division of Hematology and Medical Oncology at Mayo Clinic in Phoenix, AZ is seeking a Medical Oncologist with interest and expertise in melanoma and other cutaneous malignancies. Our ideal candidate would be an early to mid-career medical oncologist with ambition to expand the Mayo Clinic in Arizona Melanoma and other cutaneous malignancies Medical Oncology Program. The applicant will have the opportunity to teach medical students, residents, and fellows. The successful candidate will partner with our internationally recognized group including, but not limited to, dermatology, dermatologic oncology, surgical oncology, and radiation oncology teams in a multidisciplinary clinic, develop and conduct clinical trials, help recruit future colleagues and drive innovation across the spectrum of care. The successful applicant will be able to build their academic practice and reputation nationally and internationally. Mayo Clinic Arizona will provide the successful applicant with many opportunities to contribute to existing efforts, grow new programs, and pursue a personalized academic career path related to melanoma and other cutaneous malignancies research and treatment, and continue to build a reputation nationally and internationally. Cancer care at Mayo Clinic is managed collaboratively across the Arizona, Florida, and Minnesota campuses therefore the applicant will have access to the combined resources of the entire Mayo Clinic Enterprise Network. This includes over more than 250 oncologists and hematologists, CORE research facilities, pathology, clinical records, and over 2000 faculty involved in cancer care. Clinical trials are conducted in collaboration with Industry partners, the Alliance for Clinical Trials in Oncology and the NCI Experimental Therapeutics Clinical Trials Network amongst others. Additionally, Mayo Clinic has a strategic and robust relationship with Arizona State University (ASU). ASU has its headquarters located in Tempe, Arizona, and is now the largest university in the United States. It has been designated by US World and News as the most innovative university in the nation for eight years in a row. Mayo Clinic and ASU formalized their relationship in 2016 under the rubric of the Mayo Clinic and ASU Alliance for Healthcare. We have multiple areas of interaction, including research, education, innovation, and administration. Four focal areas of interest include Human Performance and Biomedical Research, Digital Connectivity, Workforce of the Future (Education), and Medical Technology. ASU built a research building in proximity to Mayo Clinic hospital, the Health Futures Center. In collaboration with ASU, we are building a biotechnology corridor called Discovery Oasis. Owning over 250 acres of land adjacent to our hospital secures strategically the future of Mayo Clinic. Individuals of Mayo Clinic can hold adjunct appointments at ASU, and in some circumstances can have students as part of the research team. Over the next four years, Mayo Clinic is making significant investments in both the physical and technological future of health care, through doubling the size of the Mayo Clinic campus in Phoenix, inclusive of practice, education, and research activities. Mayo Clinic's campuses in Arizona are located in Phoenix and Scottsdale, in the beautiful Sonoran Desert. Join an organization that provides a rewarding career and promotes excellence in patient-centered care!! It is an opportune time to join our Division and be a leader in growth and development. This is an exciting time to be in Arizona!!